ULTRAGENYX EUROPE GMBH
502078-5456ActiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2022
- Grundat
Nyckelbeslutsfattare
Emil D. Kakkis
Chief Executive Officer and President
Beskrivning
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Taggar
Nyckelord
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502078545601
Beslutsfattare
1 kontakter i FunnelfeedrEmil D. Kakkis
Chief Executive Officer and President
Liknande företag
20 liknande företag i FunnelfeedrBridgeBio International GmbH
Developing transformative medicines for rare genetic conditions quickly.
SAREPTA THERAPEUTICS, INC.
Engineering precision genetic medicine to rescue lives from rare diseases.
OxThera Intellectual Property AB
0 anställdaDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Orchard Therapeutics (Sweden) AB
1–4 anställdaDeveloping life-transforming HSC gene therapies for severe genetic diseases.
AMICUS THERAPEUTICS LTD
Global biotechnology company developing transformative medicines for rare diseases.
Frågor om ULTRAGENYX EUROPE GMBH
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo